2024-09-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NVCR
NovoCure Limited
|
Buy |
9.1% |
-0.17% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.67% |
6.04% |
2024-09-09 |
The percentage of cash held in the portfolio is:
81.23%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ESPR |
Sell
All
|
-2.73% |
Assets Rebalanced
None
2024-09-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.72% |
-3.83% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
9.1% |
-0.5% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.46% |
3.45% |
2024-09-09 |
The percentage of cash held in the portfolio is:
72.71%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
TVTX |
Sell
All
|
48.65% |
Assets Rebalanced
None
2024-09-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TVTX
Travere Therapeutics, Inc.
|
Buy |
11.92% |
27.5% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.89% |
-4.92% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
9% |
-4.54% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.18% |
-2.56% |
2024-09-09 |
The percentage of cash held in the portfolio is:
61.02%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PODD |
Sell
All
|
11.4% |
Assets Rebalanced
None
2024-09-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
10.99% |
7.2% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
12.53% |
33.96% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.69% |
-7.1% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
8.68% |
-7.98% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.49% |
0.63% |
2024-09-09 |
The percentage of cash held in the portfolio is:
49.62%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ALDX |
Sell
All
|
-6.49% |
AADI |
Sell
All
|
3.43% |
Assets Rebalanced
None
2024-09-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.88% |
4.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
10.97% |
5.05% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
10.89% |
14.37% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.58% |
-9.84% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
9.29% |
-3.01% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
8.98% |
-6.48% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.6% |
0% |
2024-09-09 |
The percentage of cash held in the portfolio is:
30.81%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.69% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
11.03% |
5.72% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.84% |
3.44% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.94% |
-6.01% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
9.56% |
0% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
9.59% |
0% |
2024-09-06 |
The percentage of cash held in the portfolio is:
40.36%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CARA |
Sell
All
|
-6.41% |
AGEN |
Sell
All
|
-8.59% |
Assets Rebalanced
None
2024-09-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.75% |
-6.12% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.21% |
-11.33% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.67% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
10.82% |
3.96% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.93% |
4.69% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.44% |
-0.55% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
9.54% |
0% |
2024-09-05 |
The percentage of cash held in the portfolio is:
30.63%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CERS |
Sell
All
|
-11.34% |
APLS |
Sell
All
|
-5.21% |
ORGO |
Sell
All
|
-4.59% |
EGRX |
Sell
All
|
-11.35% |
Assets Rebalanced
None
2024-09-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.08% |
-2.65% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.99% |
-3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10% |
-3.5% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.38% |
-9.51% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
9.52% |
-7.98% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.29% |
-0.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
10.5% |
1.11% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
9.3% |
-10.38% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.47% |
0% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.47% |
0% |
2024-09-04 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ARDX |
Sell
All
|
-11.62% |
NEOG |
Sell
All
|
-6.34% |
Assets Rebalanced
None
2024-08-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.64% |
-3.45% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.57% |
-4.2% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.34% |
3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.37% |
3.79% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.33% |
-6.58% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
9.39% |
-5.88% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
9.58% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
9.77% |
-2.15% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
10.01% |
0% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
10.01% |
0% |
2024-08-29 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.55% |
-2.35% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.72% |
-0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.16% |
3.89% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.24% |
4.66% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.07% |
2.93% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
9.53% |
-2.52% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
9.38% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
9.78% |
0% |
2024-08-28 |
The percentage of cash held in the portfolio is:
21.57%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.51% |
-0.94% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.6% |
-0.05% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.28% |
7.07% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.36% |
7.87% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.3% |
7.31% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
9.59% |
0% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
9.59% |
0% |
2024-08-27 |
The percentage of cash held in the portfolio is:
30.77%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.4% |
-5.02% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.72% |
-1.79% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.61% |
-2.83% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.9% |
0% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.9% |
0% |
2024-08-23 |
The percentage of cash held in the portfolio is:
51.48%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.8% |
0% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.8% |
0% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.8% |
0% |
2024-08-22 |
The percentage of cash held in the portfolio is:
70.6%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-12 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CYH |
Sell
All
|
-4.91% |
Assets Rebalanced
None
2024-08-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
9.14% |
-7.66% |
2024-07-29 |
The percentage of cash held in the portfolio is:
90.86%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RMD |
Sell
All
|
1.39% |
Assets Rebalanced
None
2024-08-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
9.6% |
-1.96% |
2024-07-29 |
RMD
ResMed Inc.
|
Buy |
9.62% |
7.5% |
2024-07-31 |
The percentage of cash held in the portfolio is:
80.78%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
HQY |
Sell
All
|
-11.82% |
SAVA |
Sell
All
|
95.11% |
SAGE |
Sell
All
|
-12.65% |
HCSG |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-08-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
9.92% |
-1.57% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
9.7% |
-3.84% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
15.87% |
57.44% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
8.95% |
-11.19% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
9.21% |
-3.72% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
9.5% |
3.13% |
2024-07-31 |
The percentage of cash held in the portfolio is:
36.84%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
FATE |
Sell
All
|
-12.39% |
Assets Rebalanced
None
2024-08-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.07% |
-4.31% |
2024-07-24 |
CYH
Community Health Systems, Inc.
|
Buy |
10.25% |
3.34% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
9.61% |
-3.09% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
14.77% |
48.93% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
9.88% |
-0.36% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
9.3% |
-1.12% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
9.29% |
2.5% |
2024-07-31 |
The percentage of cash held in the portfolio is:
28.84%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RCM |
Sell
All
|
-1.15% |
Assets Rebalanced
None
2024-07-31 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
9.17% |
-1% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.08% |
-7.9% |
2024-07-24 |
CYH
Community Health Systems, Inc.
|
Buy |
10.46% |
1.38% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
9.99% |
-3.16% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
12.15% |
17.76% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
10.14% |
-1.73% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
9.74% |
-0.43% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
9.43% |
0% |
2024-07-31 |
The percentage of cash held in the portfolio is:
20.86%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SMTI |
Sell
All
|
-8.69% |
CLDX |
Sell
All
|
-12.36% |
Assets Rebalanced
None
2024-07-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
8.84% |
-2.61% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.35% |
-2.87% |
2024-07-24 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
9.68% |
-4.26% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
9.56% |
-5.45% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
10.29% |
1.77% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
9.94% |
-1.69% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
12.21% |
20.78% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
9.95% |
-1.64% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
9.59% |
0% |
2024-07-30 |
The percentage of cash held in the portfolio is:
11.59%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
BKD |
Sell
All
|
4.37% |
PTGX |
Sell
All
|
-7.35% |
Assets Rebalanced
None
2024-07-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BKD
Brookdale Senior Living Inc.
|
Buy |
10.8% |
5.69% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
9.06% |
-0.19% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.4% |
-2.33% |
2024-07-24 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
8.86% |
-3.84% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
10.28% |
1.6% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
10.12% |
0% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
10.12% |
0% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
10.12% |
0% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
10.12% |
0% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
10.12% |
0% |
2024-07-29 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BKD
Brookdale Senior Living Inc.
|
Buy |
10.59% |
3.44% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
9.03% |
-0.84% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.36% |
-3.05% |
2024-07-24 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
9.16% |
-0.76% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
10.14% |
0% |
2024-07-26 |
The percentage of cash held in the portfolio is:
52.72%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ANGO |
Sell
All
|
22.51% |
SGRY |
Sell
All
|
20.35% |
AVNS |
Sell
All
|
8.22% |
Assets Rebalanced
None
2024-07-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ANGO
AngioDynamics, Inc.
|
Buy |
11.41% |
19.58% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
11.08% |
16.16% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
10.18% |
6.7% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
10.72% |
3.7% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
9.27% |
0.92% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.09% |
-7% |
2024-07-24 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
9.31% |
0% |
2024-07-25 |
The percentage of cash held in the portfolio is:
29.94%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
PDSB |
Sell
All
|
6.96% |
OPK |
Sell
All
|
7.58% |
Assets Rebalanced
None
2024-07-24 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.89% |
20.17% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
9.89% |
9.09% |
2024-07-11 |
ANGO
AngioDynamics, Inc.
|
Buy |
11.42% |
22.02% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
10.38% |
10.92% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
10.03% |
7.18% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
10.48% |
3.31% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
9.29% |
3.07% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.54% |
0% |
2024-07-24 |
The percentage of cash held in the portfolio is:
19.08%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.11% |
9.94% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
10.38% |
12.88% |
2024-07-11 |
ANGO
AngioDynamics, Inc.
|
Buy |
11.12% |
17.13% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
10.79% |
13.7% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
9.86% |
3.82% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
10.41% |
1.19% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
9.32% |
2% |
2024-07-18 |
The percentage of cash held in the portfolio is:
28.01%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
TDOC |
Sell
All
|
-2.99% |
ALT |
Sell
All
|
-16.04% |
Assets Rebalanced
None
2024-07-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.05% |
9.66% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
8.02% |
-12.43% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
10.55% |
15.15% |
2024-07-11 |
ANGO
AngioDynamics, Inc.
|
Buy |
10.73% |
13.38% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
9.4% |
-0.64% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
10.78% |
13.89% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
10.03% |
5.95% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
10.42% |
1.59% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
8.98% |
-1.46% |
2024-07-18 |
The percentage of cash held in the portfolio is:
11.04%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
WST |
Sell
All
|
-5.09% |
Assets Rebalanced
None
2024-07-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.13% |
13.92% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
8.91% |
0.13% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
9.57% |
7.58% |
2024-07-11 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
9.01% |
-1.88% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
11.09% |
20.72% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
9.83% |
7.04% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
10.62% |
15.66% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
9.82% |
6.89% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
10.17% |
2.25% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
8.84% |
0% |
2024-07-18 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
BHVN |
Sell
All
|
0.3% |
Assets Rebalanced
None
2024-07-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
11.1% |
20.03% |
2024-07-11 |
BHVN
Biohaven Ltd.
|
Buy |
9.83% |
6.27% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
9.77% |
5.61% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
10.02% |
8.33% |
2024-07-11 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
9.17% |
-3.96% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
9.24% |
-3.26% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
9.44% |
-1.17% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
9.62% |
0.74% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
9.44% |
-1.18% |
2024-07-12 |
BKD
Brookdale Senior Living Inc.
|
Buy |
10.35% |
0% |
2024-07-16 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
VRDN |
Sell
All
|
11.2% |
Assets Rebalanced
None
2024-07-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
9.36% |
-1.97% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.42% |
10.23% |
2024-07-11 |
BHVN
Biohaven Ltd.
|
Buy |
9.91% |
4.89% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
9.7% |
2.67% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
9.81% |
3.79% |
2024-07-11 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
9.76% |
0% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
9.76% |
0% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
9.76% |
0% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
9.76% |
0% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
9.76% |
0% |
2024-07-12 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CYH |
Sell
All
|
15.94% |
Assets Rebalanced
None
2024-07-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
10.34% |
4.37% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
9.2% |
-7.12% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
9.81% |
0% |
2024-07-11 |
BHVN
Biohaven Ltd.
|
Buy |
9.81% |
0% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
9.81% |
0% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
9.81% |
0% |
2024-07-11 |
The percentage of cash held in the portfolio is:
41.23%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
10.28% |
3.75% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
9.26% |
-6.59% |
2024-07-02 |
The percentage of cash held in the portfolio is:
80.47%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RARE |
Sell
All
|
6.02% |
NVRO |
Sell
All
|
-11.61% |
Assets Rebalanced
None